These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26600481)

  • 1. Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues.
    Zhu J; Li Q; He J; Ma K
    Genet Mol Res; 2015 Nov; 14(4):14239-45. PubMed ID: 26600481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
    Zhu J; Li Q; He JT; Liu GY
    Int J Clin Exp Pathol; 2015; 8(12):15801-7. PubMed ID: 26884850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
    Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
    Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of SKP2 protein in lung carcinoma and its implication for prognosis].
    Zhao J; Yang CL; Zhao SY
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):289-92. PubMed ID: 17760257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM66 expression in non-small cell lung cancer: A new predictor of prognosis.
    Ma Y; Dai HY; Zhang F; Zhao D
    Cancer Biomark; 2017 Sep; 20(3):309-315. PubMed ID: 28946563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and function of miRNA-451 in non-small cell lung cancer.
    Wang XC; Tian LL; Jiang XY; Wang YY; Li DG; She Y; Chang JH; Meng AM
    Cancer Lett; 2011 Dec; 311(2):203-9. PubMed ID: 21875770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of connexin 32 and 26 and their correlation to prognosis of non-small cell lung cancer.
    Zhang W; Li HG; Fan MJ; Lv ZQ; Shen XM; He XX
    Ai Zheng; 2009 Feb; 28(2):173-6. PubMed ID: 19550132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.